SRCAP and cancer: While the majority of studies have posited H2A.Z as a pro-carcinogenic factor, a recent study has revealed the deficient H2A.Z disposition in uterine leiomyoma cells with SRCAP complex mutations, which suggests a cancer inhibition role of H2A.Z in tumorigenesis [118].